CASE REPORT article
Front. Hematol.
Sec. Blood Cancer
This article is part of the Research TopicAn Expert View On Unmet Clinical Need in HematologyView all articles
From Static Diagnosis to Clonal Kinetics: A New Framework for Timing Allogeneic Stem Cell Transplantation in Patients with Bone Marrow Failure Syndromes—A Hypothesis-Generating Case Series
Provisionally accepted- 1Hainan General Hospital, Haikou, China
- 2Hainan Medical University, Haikou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
This retrospective study analyzed four patients with bone marrow failure (BMF) syndromes to evaluate a hypothesis for guiding allogeneic hematopoietic stem cell transplantation (allo-HSCT) based on clonal dynamics. Accurate early subclassification of BMF remains challenging, and conventional diagnosis—often reliant on static, cross-sectional assessment of clonal evolution—frequently results in delayed intervention. Case analyses indicated that serial monitoring of clonal kinetic parameters, may help identify the essential progression toward clonal hematopoiesis (e.g., myelodysplastic syndrome/MDS) earlier than traditional approaches. The presented cases could be considered that even when the initial diagnosis is ambiguous or considered "low-risk," the emergence of progressive clonal signals—such as a steadily rising ring sideroblast (RS) percentage following immunosuppressive therapy (IST) failure—may serve as a compelling indicator to actively consider transplantation. Conversely, delay in intervention may lead to missed therapeutic opportunities. We put forward a hypothesis that, in cases of refractory cytopenia unresponsive to IST, transplant decision-making may benefit from dependence on a "static diagnostic label" to an emphasis on "dynamic disease behavior." Integrating clonal kinetics monitoring into routine clinical management and prospectively evaluating transplant timing based on its trends may help improve patient outcomes.
Keywords: allogeneic hematopoietic stem cell transplantation, bone marrow failure syndromes, Clonal Dynamics Monitoring, Clonal Kinetics, immunosuppressive therapy
Received: 23 Dec 2025; Accepted: 12 Feb 2026.
Copyright: © 2026 li and huang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: li huang
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
